Mechanistically different acting tumor promoters induce consistent qualitative and quantitative changes in protein expression patterns of murine epidermis

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 385-395

  Schlatterer, K ^a   Krauter, G ^b   Schlatterer, B ^c   Hecker, E ^b   Chandra, P ^a  

^a GOETHE UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Stt Inst Vet Med and Food Chem   (Germany)

Author keywords

Dimethylbenzanthracene; Murine epidermis; Protein expression; Tumor promotion

Indexed keywords

ACETONE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; FEMALE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN; TUMOR PROMOTION;

ANIMALS; ANIMALS, NEWBORN; CARCINOGENS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; MICE; PROTEIN BIOSYNTHESIS; PROTEINS; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 0032897378     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Ali H, Christensen SB, Foreman JC, Pierce FL, Piotrowski W, Thastrup O: The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Brit J Pharmacol 85: 705-712, 1985.
2. Argyris TS: Regeneration and the mechanism of epidermal tumor promotion. CRC Crit Rev Toxicol 14: 211-258, 1985.
3. Baird WM, Sedgwick JA, Bourwell RK: Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA and protein of mouse epidermis. Cancer Res 31: 1434-1439, 1971.
4. Balmain A: The synthesis of specific proteins in adult mouse epidermis during phases of proliferation and differentiation induced by the tumor promoter TPA, and in basal and differentiating layers of neonatal mouse epidermis. J Invest Dermatol 67: 246-253, 1976.
5. Balmain A, Loehren D, Fischer J, Alsonso A: Histone phosphorylation, DNA and RNA synthesis during phases of proliferation and differentiation induced in mouse epidermis by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 37: 1548-1555, 1977.
6. Bazill G, de Wynter E, Fujiki H, Kinsella A: A comparison of the effects of tumor promoters 12-O-tetradecanoylphorbol-13-actetate and teleocidin on gene expression in human skin cell fibroblasts. Jpn J Cancer Res (Gann), 75: 672-680, 1984.
7. Bojan F, Kinsella AR, Fox M: Effect of the tumour promoter 12-O-tetradecanoylphorbol-13-acetate on recovery of methotrexate-, N-(phosphonacetyl)-2-aspartate- and cadmium-resistant colony forming mouse and hamster cells. Cancer Res 43: 5217-5221, 1983.
8. Bowen PE, Wood EJ, Cunliffe WJ: Comparison of prekeratin and keratin polypeptides in normal and psoriatic human epidermis Biochim Biophys Acta 743: 172-179, 1983.
9. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
10. Bravo R, Fey SJ, Small JV, Larsen PM, Celis JM: Co-existance of three major isoactins in a single sarcoma 180 cell Cell, 25: 195-202, 1981.
11. Cabral F, Gottesman MM, Yuspa SH: Induction of specific protein synthesis by phorbol esters in mouse epidermal cell cultures Cancer Res 41: 2025-2031, 1981.
12. Celis JE, Cruaer D, Kiil JB, Ratz G, Basse B, Celis A: Identification of a group of proteins that are strongly up-regulated in total epidermal keratinocytes from psoriatic skin FEBS Lett 262: 159-164, 1990.
13. Colbum NH, Lau S, Head R: Decrease of epidermal histidase activity by tumor promoting phorbol esters Cancer Res 35: 3154-3159, 1975.
14. De Young LM, Argyris RS, Gordon GB: Epidermal ribosome accumulation during two stage skin tumorigenesis Cancer Res 37: 388-393, 1977.
15. De Young LM, Helmes CT, Chao WR, Young JM, Miller V: Paradoxical effect of anthralin on 12-O-tetradecanoyl-phorbol-13-acetate-induced mouse epidermal omithine decarboxylase activity, proliferation and tumor promotion Cancer Res 41: 204-208, 1981.
16. DiGiovanni J: Modification of multistage skin carcinogenesis in mice in: Modification of tumor development in rodents. 33: 192-229, 1991.
17. Ito N, Sugano H. (eds.) Prog Exp Tumor Res Karger, Basel Edler L, Schmidt R, Weber E, Rippmann F, Hecker E: Biological assays for irritant, tumor initiating and -promoting activities, III. Computer-assisted management and validation of biodata generated by standardized initiation / promotion protocols in skin of mice. J Cancer Res Clin Oncol 117: 205-216, 1991.
18. Fujiki H, Sugimura T: New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin Advances in Cancer Res 49: 223-264, 1987.
19. Fujiki H, Suganuma M, Nishiwaki S, Yoshizawa S, Winyar B, Sugimura T, Schmitz FJ: A new pathway of tumor promotion by the okadaic acid class compounds. Advances in Second Messenger & Phosphoprotein Research 24: 340-344, 1990.
20. Fujiki H: Okadaic acid class of tumor promoters for mouse skin and rat glandluar stomach: tumor promotion and mechanisms of action. J Cancer Res Clin Oncol 116 suppl 16.21.08, 1990.
21. Furstenberger G, Berry DL, Sorg B, Marks F: Skin tumor promotion by phorbol esters is a two stage process. Proc Natl Acad Sci U.S.A. 78: 7722-7726, 1981.
22. Gothan SM, Fryer PJ, Paterson WR: The measurement of insoluble proteins using a modified Bradford assay. Anal Biochem 173: 353-358, 1988.
23. Gottlieb AB, Luster AD, Posnett DN, Carter DM: Detection of a γ-interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 168: 941-948, 1988.
24. Gschwendt M, Furstenberger G, Rose-John S, Rogers M, Kittstein W, Pettit GR, Herald CL, Marks F: Bryostatin 1, an activator of protein kinase C mimics as well as inhibits effects of the phorbol ester TPA in vivo and in vitro. Carcinogenesis 9: 555-562, 1988.
25. Hecker E: Three stage carcinogenesis in mouse skin - recent results and present status of an advanced model system of chemical carcinogenesis. Toxicol Pathol 15: 245-258, 1987.
26. Hiwasa T, Fujimura S, Sakiyama S: Tumor promoters increase the synthesis of a 32,000-dalton protein in BALB/c 3T3 cells. Proc Natl Acad Sci U.S.A. 79: 1800-1804, 1982.
27. Kakunaga T, Leavitt J, Hamada H, Hirakawa T: A point mutation in β-actin gene and neoplastic transformation. In: Genes and Proteins in Oncogenesis Weinstein IB, Vogel H (eds.), pp. 351-367 Academic Press, New York, 1983.
28. Kaplan G, Luster AD, Hancock G, Cohn ZA: The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 166: 1098-1108, 1987.
29. Krieg L, Kuhlmann I, Marks F: Effect of the tumor promoting phorbol esters and of acetic acid on mechanisms controlpng DNA synthesis and mitosis (chalones) and on the biosynthesis of histidine rich proteins in mouse epidermis. Cancer Res 34: 3135-3146, 1974.
30. Krueger JG, Krane JF, Carter M, Gottlieb AB: Role of growth factors, cytokines, and their receptors in te pathogenesis of psoriasis. J Invest Dermatol 94: 135S-140S, 1990.
31. Kupper T: Mechanisms of cutaneous inflammation. Arch Dermatol 125: 1406-1412, 1989.
32. Laskin JD, Mufson RA, Piccini L, Engelhardt DL, Weinstein IB: Effects of the tumour promoter 12-O-tetradecanoylphorbol-13-acetate on newly synthesized proteins in mouse epidermis. Cell 25: 441-449, 1981.
33. Leavitt J, Kakunaga T: Expression of a variant form of actin and additional polypeptide changes following chemical-induced in vitro neoplastic transformation of human fibroblasts. J Biol Chem 255: 1650-1661, 1980.
34. Leavitt J, Ng SY, Varma M, Latter G, Burbeck S, Gunning P, Kedes L: Expression of transfected mutant β-actin genes: transitions toward the stable tumorigenic state. Mol Cell Biol 7: 2467-2476, 1987.
35. Leavitt J, Ng SY, Aebi U, Varma M, Latter G, Burbeck S, Kedes L, Gunning P: Expression of transfected mutant β-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools. Mol Cell Biol 7: 2457-2466, 1987.
36. Luster AD, Ravetch JV: Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site. Mol Cell Biol 7: 3723-3731, 1987.
37. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, Lauridsen JB, Ratz GP, Celis A, Vandekerckhove J, Celis JE: Molecular cloning, occurrence, and expression of a novel partailly secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 97: 701-712, 1991.
38. Marks F, Furstenberger G, Koronatzki E: Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate Cancer Res 41: 696-702, 1981.
39. Meyer SA, Kim TW, Moser GJ, Monteiro-Rivere NA, Smart RC: Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion Carcinogenesis, 15, 47-52, 1994.
40. Molloy CJ, Laskin JD: Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetra,decanoylphorbol-13-acetate Cancer Res 47: 4674-4680, 1987.
41. Moser GJ, Smart RC: Hepatic tumour-promoting chlorinated hydrocarbons stimulate protein kinase C activity Carcinogenesis, 10: 851-856, 1989.
42. Moser GJ, Meyer SA, Smart RC: The chlorinated pesticide mirex is a novel nonphorbol ester-type tumor promoter in mouse skin Cancer Res 52: 631-636, 1992.
43. Moser GJ, Robinette CL, Smart RC: Characterization of skin tumor promotion by mirex: structure-activity relationships, sexual dimorphism and presence of Ha-ras mutation Carcinoaenesis, 14: 1155-1160, 1993.
44. Mufson RA, DeFeo D, Weinstein IB: Effect of phorbol ester tumor promoters on arachidonic acid metabolism in chick embryo fibroblasts. Mol Pharm 16: 569-578, 1979b.
45. Naito M, Naito Y, DiGiovanni J: Comparison of the histological changes in the skin of DBA 2 and C57BU6 mice following exposure to various promoting agents. Carcinogenesis 8: 1807-1815, 1987.
46. Neuhoff V, Arold N, Taube D, Ehrhardt W: Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9: 255-262, 1988.
47. O'Brien TG, Simsiman RC, Boutwell RK: Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tum promoting agents. Cancer Res 35: 1662-1670, 1975.
48. O'Brien TG, Diamond L: Omithine decarboxylase, polyamines and tumor promoters. Carcinogenesis 2: 273-289, 1978.
49. Ostrowski LE, Krieg P, Finch J, Cress AE, Nagle RB, Bowden GT: Expression of β-actin during progression of mouse skin tumors Carcinogenesis 10: 1439-1444, 1989.
50. Raick AN: Late ultrastructural changes induced by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis and their reversal Cancer Res 33: 1096-1103, 1973.
51. Rohrschneider LR, Boutwell RK: The early stimulation of phospholipid metabolism in mouse skin by 12-O-tetradecanoylphorbol-13-acetate and its specifity for tumor promotion Cancer Res 33: 1945-1952, 1973.
52. Rotenbera SA, Weinstein IB: Two polychlorinated hydrocarbons cause phospholipid-dependent protein kinase C activation in the absence of calcium. Mol Carcinogenesis 4: 477-481, 1991.
53. Scribner JD, Suss R: Tumor initiation and promotion. In: International Review of Experimental Pathology, 18, 137-198 Richter GW, Epstein MA (eds.) Academic Press, New York, 1978.
54. Segal A, Katz C, Van Duuren BL: Structure and tumor promoting activity of anthralin (1,8-dihydroxy-9-anthrone) and related compounds. J Med Chem 14: 1152-1154, 1971.
55. Smoller BR, McNutt NS, Gray MH, Krueger J, Hsu A, Gottlieb AB: Detection of the interferon-gamma-induced protein 10 in psoriasiform dermatitis of aquired immunodeficiency syndrome Arch. Dermatol 126: 1457-1461, 1990.
56. Suganuma S, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Kakamatsu K, Yamada K, Sugimura T: Okadaic acid: an additional non-phorhol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci U.S.A. 85: 1768-1771, 1988.
57. ++ dependent protein kinase. Biochem Biophys Res Commun 135: 397-402, 1986.
58. Thastrup O: The calcium mobilizing and tumor promoting agent thapsigargin elevates the platelet cytoplasmatic free calcium concentration to a higher steady state level. A possible mechanism of action for tumor promotion Biochem. Biophys. Res. Commun 142: 654-659, 1987.
59. ++ stores by specific inhibition of the endoplasmatic reticulum. Proc Natl Acad Sci U.S.A. 87: 2466-2470, 1990.
60. Towbin H Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U.S.A. 76: 4350-4354, 1979.
61. Viaje A, Slaga TJ, Wigler M, Weinstein IB: Effects of anti-inflammatory agents on mouse skin tumor promtion, epidermal DNA synthesis, phorbol-ester-induced cellular proliferation and production of plasminogen activator. Cancer Res 37: 1530-1536, 1977.
62. Yamamoto S, Kiyoto I, Aizu E, Nakadate T, Hosoda Y, Kato R: 1989. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promtion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation. Carcinogenesis 10: 1315-1322, 1977.
63. Yoshizawa S, Fujiki H, Suguri H, Suganuma M, Nakayasu M, Matsushima R, Sugimura T: Tumor-promoting activity of staurosporine, a protein kinase C inhibitor, on mouse skin Cancer Res 50: 4974-4978, 1990.
64. Zur Hausen HZ, O Neill FJ, Freese UK, Hecker E: Persisting oncogenic herpes virus induced by the tumour promoter TPA Nature (London) 272: 373-375, 1978.